Glycobond was established in 2011 by researchers at Linköping University (Sweden). The privately held and independent company is located in Linköping. During 2012-2015 the company was part of LEAD, a renown Swedish business incubator that has worked with hundreds of start-up companies.
The characterization and detection of glycoproteins is the core competence of Glycobond. More specifically, the research is focused on specific carbohydrate changes in cancer cells and the diagnostic use of glycoproteins as tumour markers.
Glycobond's proprietary carbohydrate-binding reagents offer a new way of detecting carbohydrate biomarkers.
Glycobond has a unique competence that encompasses knowledge within carbohydrate anaysis, protein biochemistry and clinical diagnosis.